358
Views
1
CrossRef citations to date
0
Altmetric
Reviews

The delayed effects of acute radiation exposure (DEARE): characteristics, mechanisms, animal models, and promising medical countermeasures

ORCID Icon & ORCID Icon
Pages 1066-1079 | Received 13 Dec 2022, Accepted 20 Feb 2023, Published online: 16 Mar 2023

References

  • Abrams HL. 1951. Influence of age, body weight, and sex on susceptibility of mice to the lethal effects of X-radiation. Proc Soc Exp Biol Med. 76(4):729–732.
  • Al-Jumayli M, Brown SL, Chetty IJ, Extermann M, Movsas B. 2022. The biological process of aging and the impact of ionizing radiation. Semin Radiat Oncol. 32(2):172–178.
  • Anscher MS, Thrasher B, Zgonjanin L, Rabbani ZN, Corbley MJ, Fu K, Sun L, Lee WC, Ling LE, Vujaskovic Z. 2008. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 71(3):829–837.
  • Antonadou D, Coliarakis N, Synodinou M, Athanassiou H, Kouveli A, Verigos C, Georgakopoulos G, Panoussaki K, Karageorgis P, Throuvalas N. 2001. Randomized phase III trial of radiation treatment +/– amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 51(4):915–922.
  • Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, Migrino RQ, Doppalapudi A, Harmann L, Allen Li X, et al. 2009. 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol. 85(12):1089–1100.
  • Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. 2003. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22(16):4212–4222.
  • Bertho JM, Frick J, Prat M, Demarquay C, Dudoignon N, Trompier F, Gorin NC, Thierry D, Gourmelon P. 2005. Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model. Int J Radiat Oncol Biol Phys. 63(3):911–920.
  • Blakely EA. 2000. Biological effects of cosmic radiation: deterministic and stochastic. Health Phys. 79(5):495–506.
  • Boerma M, Wang J, Sridharan V, Herbert JM, Hauer-Jensen M. 2013. Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart. PLOS One. 8(7):e70479.
  • Booth C, Tudor G, Tonge N, Shea-Donohue T, MacVittie TJ. 2012. Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 103(4):400–410.
  • Booth C, Tudor GL, Katz BP, MacVittie TJ. 2015. The delayed effects of acute radiation syndrome: evidence of long-term functional changes in the clonogenic cells of the small intestine. Health Phys. 109(5):399–413.
  • Brook I. 2020. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 38(2):84–92.
  • Casarett A. 1968. Radiation biology. Englewood (NJ): Prentice-Hall Inc.
  • Chen L, Brizel DM, Rabbani ZN, Samulski TV, Farrell CL, Larrier N, Anscher MS, Vujaskovic Z. 2004. The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int J Radiat Oncol Biol Phys. 60(5):1520–1529.
  • Chen T, Zhuang B, Huang Y, Wang W, Jin Y. 2022. Inhaled amifostine for the prevention of radiation-induced lung injury. Radiat Med Prot. 3(2):72–80.
  • Chodick G, Bekiroglu N, Hauptmann M, Alexander BH, Freedman DM, Doody MM, Cheung LC, Simon SL, Weinstock RM, Bouville A, et al. 2008. Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol. 168(6):620–631.
  • Choi JS, Shin HS, An HY, Kim YM, Lim JY. 2017. Radioprotective effects of keratinocyte growth factor-1 against irradiation-induced salivary gland hypofunction. Oncotarget. 8(8):13496–13508.
  • Chong MJ, Murray MR, Gosink EC, Russell HR, Srinivasan A, Kapsetaki M, Korsmeyer SJ, McKinnon PJ. 2000. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc Natl Acad Sci U S A. 97(2):889–894.
  • Chua HL, Plett PA, Fisher A, Sampson CH, Vemula S, Feng H, Sellamuthu R, Wu T, MacVittie TJ, Orschell CM. 2019. Lifelong residual bone marrow damage in murine survivors of the hematopoietic acute radiation syndrome (H-ARS): a compilation of studies comprising the Indiana University experience. Health Phys. 116(4):546–557.
  • Chua HL, Plett PA, Sampson CH, Joshi M, Tabbey R, Katz BP, MacVittie TJ, Orschell CM. 2012. Long-term hematopoietic stem cell damage in a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 103(4):356–366.
  • Chua HL, Plett PA, Sampson CH, Katz BP, Carnathan GW, MacVittie TJ, Lenden K, Orschell CM. 2014. Survival efficacy of the pegylated G-CSF Maxy-G34 and Neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors. Health Phys. 106(1):21–38.
  • Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, et al. 2004. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet. 36(11):1133–1137.
  • Claria J. 2003. Cyclooxygenase-2 biology. Curr Pharm Des. 9(27):2177–2190.
  • Cogan DG, Donaldson DD, Reese AB. 1952. Clinical and pathological characteristics of radiation cataract. AMA Arch Ophthalmol. 47(1):55–70.
  • Cohen EP, Bedi M, Irving AA, Jacobs E, Tomic R, Klein J, Lawton CA, Moulder JE. 2012. Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Phys. 83(1):292–296.
  • Cohen EP, Pais P, Moulder JE. 2010. Chronic kidney disease after hematopoietic stem cell transplantation. Semin Nephrol. 30(6):627–634.
  • Cole LJ, Haire HM, Alpen EL. 1967. Partial shielding of dogs: effectiveness of small external epicondylar lead cuffs against lethal X-radiation. Radiat Res. 32(1):54–63.
  • Coleman CN, Sullivan JM, Bader JL, Murrain-Hill P, Koerner JF, Garrett AL, Weinstock DM, Case C Jr, Hrdina C, Adams SA, et al. 2015. Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise. Health Phys. 108(2):149–160.
  • Collaborative Cross Consortium. 2012. The genome architecture of the Collaborative Cross mouse genetic reference population. Genetics. 190(2):389–401.
  • Cox GN, Lee JI, Rosendahl MS, Chlipala EA, Doherty DH. 2020. Characterization of a long-acting site-specific PEGylated murine GM-CSF analog and analysis of its hematopoietic properties in normal and cyclophosphamide-treated neutropenic rats. Protein J. 39(2):160–173.
  • Crosfill ML, Lindop PJ, Rotblat J. 1959. Variation of sensitivity to ionizing radiation with age. Nature. 183(4677):1729–1730.
  • Crossen JR, Garwood D, Glatstein E, Neuwelt EA. 1994. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 12(3):627–642.
  • Cucinotta FA, Manuel FK, Jones J, Iszard G, Murrey J, Djojonegro B, Wear M. 2001. Space radiation and cataracts in astronauts. Radiat Res. 156(5):460–466.2.0.CO;2]
  • Cui W, Zhang P, Hankey KG, Xiao M, Farese AM, MacVittie TJ. 2021. AEOL 10150 alleviates radiation-induced innate immune responses in non-human primate lung tissue. Health Phys. 121(4):331–344.
  • Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. 2003. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program. 2003:473–496.
  • Davis TA, Landauer MR, Mog SR, Barshishat-Kupper M, Zins SR, Amare MF, Day RM. 2010. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Exp Hematol. 38(4):270–281.
  • Day RM, Barshishat-Kupper M, Mog SR, McCart EA, Prasanna PG, Davis TA, Landauer MR. 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res. 49(4):361–372.
  • Douple EB, Mabuchi K, Cullings HM, Preston DL, Kodama K, Shimizu Y, Fujiwara S, Shore RE. 2011. Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med Public Health Prep. 5(Suppl. 1):S122–S133.
  • Down JD, Berman AJ, Warhol M, Yeap B, Mauch P. 1990. Late complications following total-body irradiation and bone marrow rescue in mice: predominance of glomerular nephropathy and hemolytic anemia. Int J Radiat Biol. 57(3):551–565.
  • Du SS, Qiang M, Zeng ZC, Zhou J, Tan YS, Zhang ZY, Zeng HY, Liu ZS. 2010. Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-β signaling in the rat. Int J Radiat Oncol Biol Phys. 78(5):1513–1523.
  • Durand T, Bernier MO, Leger I, Taillia H, Noel G, Psimaras D, Ricard D. 2015. Cognitive outcome after radiotherapy in brain tumor. Curr Opin Oncol. 27(6):510–515.
  • Dynlacht JR, Garrett J, Joel R, Lane K, Mendonca MS, Orschell CM. 2017. Further Characterization of the mitigation of radiation lethality by protective wounding. Radiat Res. 187(6):732–742.
  • Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W 3rd, Cohen DM, MacVittie TJ. 2012. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 103(4):367–382.
  • Farese AM, Hankey KG, Cohen MV, MacVittie TJ. 2015. Lymphoid and myeloid recovery in rhesus macaques following total body X-irradiation. Health Phys. 109(5):414–426.
  • Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, Najafi M. 2020. TGF-β in radiotherapy: mechanisms of tumor resistance and normal tissues injury. Pharmacol Res. 155:104745.
  • Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, et al. 1998. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58(5):933–939.
  • Finch SC, Hrubec Z, Nefzger MD, Hoshino T, Itoga T. 1965. Detection of leukemia and related disorders, Hiroshima and Nagasaki; research plan. Hiroshima, Japan: Atomic Bomb Casualty Commission.
  • Fish BL, Gao F, Narayanan J, Bergom C, Jacobs ER, Cohen EP, Moulder JE, Orschell CM, Medhora M. 2016. Combined hydration and antibiotics with lisinopril to mitigate acute and delayed high-dose radiation injuries to multiple organs. Health Phys. 111(5):410–419.
  • Fish BL, MacVittie TJ, Gao F, Narayanan J, Gasperetti T, Scholler D, Sheinin Y, Himburg HA, Hart B, Medhora M. 2021. Rat models of partial-body irradiation with bone marrow-sparing (Leg-out PBI) designed for FDA approval of countermeasures for mitigation of acute and delayed injuries by radiation. Health Phys. 121(4):419–433.
  • Fish BL, MacVittie TJ, Szabo A, Moulder JE, Medhora M. 2020. WAG/RijCmcr rat models for injuries to multiple organs by single high dose ionizing radiation: similarities to nonhuman primates (NHP). Int J Radiat Biol. 96(1):81–92.
  • Flechsig P, Dadrich M, Bickelhaupt S, Jenne J, Hauser K, Timke C, Peschke P, Hahn EW, Gröne HJ, Yingling J, et al. 2012. LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals. Clin Cancer Res. 18(13):3616–3627.
  • Food and Drug Administration, HHS. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist. 67(105):37988–37998.
  • Fred SS, Smith WW. 1967. Radiation sensitivity and proliferative recovery of hemopoietic stem cells in weanling as compared to adult mice. Radiat Res. 32(2):314–326.
  • Fu Q, Berbée M, Boerma M, Wang J, Schmid HA, Hauer-Jensen M. 2009. The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion. Radiat Res. 171(6):698–707.
  • Fu Q, Berbée M, Wang W, Boerma M, Wang J, Schmid HA, Hauer-Jensen M. 2011. Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action. Radiat Res. 175(6):728–735.
  • Furby A, Béhin A, Lefaucheur JP, Beauvais K, Marcorelles P, Mussini JM, Bassez G, Créange A, Eymard B, Pénisson-Besnier I. 2010. Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series. J Neurol Neurosurg Psychiatry. 81(1):101–104.
  • Furukawa K, Cologne JB, Shimizu Y, Ross NP. 2009. Predicting future excess events in risk assessment. Risk Anal. 29(6):885–899.
  • Gao F, Fish BL, Moulder JE, Jacobs ER, Medhora M. 2013. Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35 days after whole-thorax irradiation. Radiat Res. 180(5):546–552.
  • Garofalo MC, Ward AA, Farese AM, Bennett A, Taylor-Howell C, Cui W, Gibbs A, Prado KL, MacVittie TJ. 2014. A pilot study in rhesus macaques to assess the treatment efficacy of a small molecular weight catalytic metalloporphyrin antioxidant (AEOL 10150) in mitigating radiation-induced lung damage. Health Phys. 106(1):73–83.
  • Garrett J, Orschell CM, Mendonca MS, Bigsby RM, Dynlacht JR. 2014. Subcutaneous wounding postirradiation reduces radiation lethality in mice. Radiat Res. 181(6):578–583.
  • Garrett J, Sampson CH, Plett PA, Crisler R, Parker J, Venezia R, Chua HL, Hickman DL, Booth C, MacVittie T, et al. 2018. Characterization and etiology of swollen muzzles in irradiated mice. Radiat Res. 191(1):31–42.
  • Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL, Medhora M. 2021. Polypharmacy to mitigate acute and delayed radiation syndromes. Front Pharmacol. 12:634477.
  • Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE, Jacobs ER, Medhora M. 2009. Renin–angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys. 75(5):1528–1536.
  • Glatstein E, Fajardo LF, Brown JM. 1977. Radiation injury in the mouse kidney – I. Sequential light microscopic study. Int J Radiat Oncol Biol Phys. 2(9–10):933–943.
  • Glover D, Fox KR, Weiler C, Kligerman MM, Turrisi A, Glick JH. 1988. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy. Pharmacol Ther. 39(1–3):3–7.
  • Grahn D. 1958. Acute radiation response of mice from a cross between radiosensitive and radioresistant strains. Genetics. 43(5):835–843.
  • Grahn D, Hamilton KF. 1957. Genetic variation in the acute lethal response of four inbred mouse strains to whole body X-irradiation. Genetics. 42(3):189–198.
  • Ha CT, Li XH, Fu D, Xiao M, Landauer MR. 2013. Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation. Radiat Res. 180(3):316–325.
  • Halle M, Gabrielsen A, Paulsson-Berne G, Gahm C, Agardh HE, Farnebo F, Tornvall P. 2010. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol. 55(12):1227–1236.
  • Hanson WR. 1987. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents. Radiat Res. 111(2):361–373.
  • Hanson WR, Grdina DJ. 1987. Radiation-induced DNA single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. Int J Radiat Biol Relat Stud Phys Chem Med. 52(1):67–76.
  • Hanson WR, Houseman KA, Nelson AK, Collins PW. 1988. Radiation protection of the murine intestine by misoprostol, a prostaglandin E1 analogue, given alone or with WR-2721, is stereospecific. Prostaglandins Leukot Essent Fatty Acids. 32(3):101–105.
  • Hanson WR, Thomas C. 1983. 16, 16-Dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat Res. 96(2):393–398.
  • Harizi H, Corcuff JB, Gualde N. 2008. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 14(10):461–469.
  • Hauer-Jensen M. 2014. Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergencies. Dig Dis Sci. 59(7):1349–1351.
  • Hauer-Jensen M, Denham JW, Andreyev HJN. 2014. Radiation enteropathy – pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 11(8):470–479.
  • Hérodin F, Roy L, Grenier N, Delaunay C, Baugé S, Vaurijoux A, Grégoire E, Martin C, Alonso A, Mayol JF, et al. 2007. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose. Exp Hematol. 35(8):1172–1181.
  • Herranz N, Gil J. 2018. Mechanisms and functions of cellular senescence. J Clin Investig. 128(4):1238–1246.
  • Hoggatt J, Singh P, Sampath J, Pelus LM. 2009. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 113(22):5444–5455.
  • Hoggatt J, Singh P, Stilger KN, Plett PA, Sampson CH, Chua HL, Orschell CM, Pelus LM. 2013. Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation. Blood Cells Mol Dis. 50(3):147–153.
  • Hospers GA, Eisenhauer EA, de Vries EG. 1999. The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects. Br J Cancer. 80(5–6):629–638.
  • Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, Amenomori T, Yamamura M, Yoshida Y, Koba T, et al. 2011. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 29(4):428–434.
  • Jaal J, Dörr W. 2007. Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction. Int J Radiat Oncol Biol Phys. 69(2):528–533.
  • Jackson IL, Zodda A, Gurung G, Pavlovic R, Kaytor MD, Kuskowski MA, Vujaskovic Z. 2017. BIO 300, a nanosuspension of genistein, mitigates pneumonitis/fibrosis following high-dose radiation exposure in the C57L/J murine model. Br J Pharmacol. 174(24):4738–4750.
  • Jacobs ER, Narayanan J, Fish BL, Gao F, Harmann LM, Bergom C, Gasperetti T, Strande JL, Medhora M. 2019. Cardiac remodeling and reversible pulmonary hypertension during pneumonitis in rats after 13-Gy partial-body irradiation with minimal bone marrow sparing: effect of lisinopril. Health Phys. 116(4):558–565.
  • Jones JW, Alloush J, Sellamuthu R, Chua HL, MacVittie TJ, Orschell CM, Kane MA. 2019. Effect of gender on biomarker response in a mouse model of the hematopoietic acute radiation syndrome. Health Phys. 116(4):484–502.
  • Kajimura J, Kyoizumi S, Kubo Y, Misumi M, Yoshida K, Hayashi T, Imai K, Ohishi W, Nakachi K, Weng NP, et al. 2016. Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors. Mutat Res Genet Toxicol Environ Mutagen. 802:59–65.
  • Kalinski P. 2012. Regulation of immune responses by prostaglandin E2. J Immunol (Baltimore, Md: 1950). 188(1):21–28.
  • Kallman RF, Kohn HI. 1956. Age, growth, and the LD50 of X-rays. Science. 124(3231):1078.
  • Kamiya K, Ozasa K, Akiba S, Niwa O, Kodama K, Takamura N, Zaharieva EK, Kimura Y, Wakeford R. 2015. Long-term effects of radiation exposure on health. Lancet. 386(9992):469–478.
  • Kaye JA. 1996. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor). Stem Cells. 14(Suppl. 1):256–260.
  • Kuhn V, Diederich L, Keller T, Kramer CM, Lückstädt W, Panknin C, Suvorava T, Isakson BE, Kelm M, Cortese-Krott MM. 2017. Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia. Antioxid Redox Signal. 26(13):718–742.
  • Kumar VP, Biswas S, Sharma NK, Stone S, Fam CM, Cox GN, Ghosh SP. 2018. PEGylated IL-11 (BBT-059): a novel radiation countermeasure for hematopoietic acute radiation syndrome. Health Phys. 115(1):65–76.
  • Landauer MR, Harvey AJ, Kaytor MD, Day RM. 2019. Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome. J Radiat Res. 60(3):308–317.
  • Langendorff H, Langendorff M. 1966. Studies on biological radiation protection. 68. Radiation sensitivity and protective effect of serotonin on mice of various ages. Strahlentherapie. 129(3):425–431.
  • Lee HT, Park SW, Kim M, Ham A, Anderson LJ, Brown KM, D'Agati VD, Cox GN. 2012. Interleukin-11 protects against renal ischemia and reperfusion injury. Am J Physiol Renal Physiol. 303(8):F1216–F1224.
  • Lenarczyk M, Lam V, Jensen E, Fish BL, Su J, Koprowski S, Komorowski RA, Harmann L, Migrino RQ, Li XA, et al. 2013. Cardiac injury after 10 Gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res. 180(3):247–258.
  • Lindop PJ, Rotblat J. 1962. The age factor in the susceptibility of man and animals to radiation. I. The age factor in radiation sensitivity in mice. Br J Radiol. 35:23–31.
  • López M, Martín M. 2011. Medical management of the acute radiation syndrome. Rep Pract Oncol Radiother. 16(4):138–146.
  • Lozano G, Zambetti GP. 2005. What have animal models taught us about the p53 pathway? J Pathol. 205(2):206–220.
  • MacVittie TJ. 2012. The MCART Consortium animal models series. Health Phys. 103(4):340–342.
  • MacVittie TJ. 2014. The MCART Consortium animal models series: an evolving MCART. Health Phys. 106(1):1–6.
  • MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, Shea-Donohue T, Gelfond D, McFarland E, Jackson W, et al. 2012. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation. Health Phys. 103(4):427–453.
  • MacVittie TJ, Bennett AW, Farese AM, Taylor-Howell C, Smith CP, Gibbs AM, Prado K, Jackson W 3rd. 2015. The effect of radiation dose and variation in Neupogen(R) initiation schedule on the mitigation of myelosuppression during the concomitant GI-ARS and H-ARS in a nonhuman primate model of high-dose exposure with marrow sparing. Health Phys. 109(5):427–439.
  • MacVittie TJ, Bennett AW, M VC, Farese AM, Higgins A, Hankey KG. 2014. Immune cell reconstitution after exposure to potentially lethal doses of radiation in the nonhuman primate. Health Phys. 106(1):84–96.
  • MacVittie TJ, Farese AM. 2020. Defining the concomitant multiple organ injury within the ARS and DEARE in an animal model research platform. Health Phys. 119(5):519–526.
  • MacVittie TJ, Farese AM. 2021. Recent advances in medical countermeasure development against acute radiation exposure based on the US FDA animal rule. J Radiol Prot. 41(4).
  • MacVittie TJ, Farese AM, Kane MA. 2019. ARS, DEARE, and multiple-organ injury: a strategic and tactical approach to link radiation effects, animal models, medical countermeasures, and biomarker development to predict clinical outcome. Health Phys. 116(4):453–453.
  • MacVittie TJ, Gibbs A, Farese AM, Barrow K, Bennett A, Taylor-Howell C, Kazi A, Prado K, Parker G, Jackson W III. 2017. AEOL 10150 mitigates radiation-induced lung injury in the nonhuman primate: morbidity and mortality are administration schedule-dependent. Radiat Res. 187(3):298–318.
  • Maier R, Ganu V, Lotz M. 1993. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem. 268(29):21527–21532.
  • Maillie HD, Krasavage W, Mermagen H. 1966. On the partial-body irradiation of the dog. Health Phys. 12(7):883–887.
  • Markovic T, Jakopin Z, Dolenc MS, Mlinaric-Rascan I. 2017. Structural features of subtype-selective EP receptor modulators. Drug Discov Today. 22(1):57–71.
  • Mauch P, Rosenblatt M, Hellman S. 1988. Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood. 72(4):1193–1196.
  • Meadows SK, Dressman HK, Daher P, Himburg H, Russell JL, Doan P, Chao NJ, Lucas J, Nevins JR, Chute JP. 2010. Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLOS One. 5(7):e11535.
  • Medhora M, Gao F, Gasperetti T, Narayanan J, Khan AH, Jacobs ER, Fish BL. 2019. Delayed effects of acute radiation exposure (DEARE) in juvenile and old rats: mitigation by lisinopril. Health Phys. 116(4):529–545.
  • Medhora M, Gao F, Wu Q, Molthen RC, Jacobs ER, Moulder JE, Fish BL. 2014. Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs. Radiat Res. 182(5):545–555.
  • Meng A, Wang Y, Van Zant G, Zhou D. 2003. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63(17):5414–5419.
  • Milsap RL, Jusko WJ. 1994. Pharmacokinetics in the infant. Environ Health Perspect. 102(Suppl. 11):107–110.
  • Mittal SO, Katirji B. 2017. Parascapular muscle atrophy as a delayed effect of radiation treatment. Pract Neurol. 17(2):127–127.
  • Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, Wolfe LF, Brizio-Molteni L, Veno P. 2000. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol. 76(4):523–532.
  • Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. 1988. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 16(5):344–348.
  • Moroni M, Coolbaugh TV, Lombardini E, Mitchell JM, Moccia KD, Shelton LJ, Nagy V, Whitnall MH. 2011. Hematopoietic radiation syndrome in the Gottingen minipig. Radiat Res. 176(1):89–101.
  • Moroni M, Ngudiankama BF, Christensen C, Olsen CH, Owens R, Lombardini ED, Holt RK, Whitnall MH. 2013. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation. Int J Radiat Oncol Biol Phys. 86(5):986–992.
  • Morton JI, Siegel BV. 1971. Radiation sensitivity of New Zealand black mice and the development of autoimmune disease and neoplasia. Proc Natl Acad Sci U S A. 68(1):124–126.
  • Moulder JE, Cohen EP. 2007. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol. 17(2):141–148.
  • Moulder JE, Cohen EP, Fish BL. 2011. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res. 175(1):29–36.
  • Moulder JE, Cohen EP, Fish BL. 2014. Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors. Int J Radiat Biol. 90(9):762–768.
  • Movsas B, Raffin TA, Epstein AH, Link CJ Jr. 1997. Pulmonary radiation injury. Chest. 111(4):1061–1076.
  • Murigi FN, Mohindra P, Hung C, Salimi S, Goetz W, Pavlovic R, Jackson IL, Vujaskovic Z. 2015. Dose optimization study of AEOL 10150 as a mitigator of radiation-induced lung injury in CBA/J mice. Radiat Res. 184(4):422–432.
  • Nasrallah R, Hassouneh R, Hebert RL. 2016. PGE2, kidney disease, and cardiovascular risk: beyond hypertension and diabetes. J Am Soc Nephrol. 27(3):666–676.
  • Nørregaard R, Kwon T-H, Frøkiær J. 2015. Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney. Kidney Res Clin Pract. 34(4):194–200.
  • Obrador E, Salvador R, Villaescusa JI, Soriano JM, Estrela JM, Montoro A. 2020. Radioprotection and radiomitigation: from the bench to clinical practice. Biomedicines. 8(11):461.
  • Orazi A, Du X, Yang Z, Kashai M, Williams DA. 1996. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest. 75(1):33–42.
  • Orschell CM, Wu T, Patterson AM. 2022. Impact of age, sex, and genetic diversity in murine models of the hematopoietic acute radiation syndrome (H-ARS) and the delayed effects of acute radiation exposure (DEARE). Curr Stem Cell Rep. 8(3):139–149.
  • Ostheim P, Haupt J, Schüle S, Herodin F, Valente M, Drouet M, Majewski M, Port M, Abend M. 2020. Differentiating total- or partial-body irradiation in baboons using mRNA expression patterns: a proof of concept. Radiat Res. 194(5):476–484.
  • Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. 2012. Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res. 177(3):229–243.
  • Pamujula S, Graves RA, Freeman T, Srinivasan V, Bostanian LA, Kishore V, Mandal TK. 2004. Oral delivery of spray dried PLGA/amifostine nanoparticles. J Pharm Pharmacol. 56(9):1119–1125.
  • Patchen ML. 1995. Amifostine plus granulocyte colony-stimulating factor therapy enhances recovery from supralethal radiation exposures: preclinical experience in animals models. Eur J Cancer. 31A(Suppl. 1):S17–S21.
  • Patchen ML, MacVittie TJ, Souza LM. 1992. Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival. Int J Radiat Oncol Biol Phys. 22(4):773–779.
  • Patterson AM, Liu L, Sampson CH, Plett PA, Li H, Singh P, Mohammad KS, Hoggatt J, Capitano ML, Orschell CM, et al. 2020. A single radioprotective dose of prostaglandin E(2) blocks irradiation-induced apoptotic signaling and early cycling of hematopoietic stem cells. Stem Cell Rep. 15(2):358–373.
  • Patterson AM, Plett PA, Chua HL, Sampson CH, Fisher A, Feng H, Unthank JL, Miller SJ, Katz BP, MacVittie TJ, et al. 2020. Development of a model of the acute and delayed effects of high dose radiation exposure in Jackson diversity outbred mice; comparison to inbred C57BL/6 mice. Health Phys. 119(5):633–646.
  • Patterson AM, Sellamuthu R, Plett PA, Sampson CH, Chua HL, Fisher A, Vemula S, Feng H, Katz BP, Tudor G, et al. 2021. Establishing pediatric mouse models of the hematopoietic acute radiation syndrome and the delayed effects of acute radiation exposure. Radiat Res. 195(4):307–323.
  • Patterson AM, Vemula S, Plett PA, Sampson CH, Chua HL, Fisher A, Wu T, Sellamuthu R, Feng H, Katz BP, et al. 2022. Age and sex divergence in hematopoietic radiosensitivity in aged mouse models of the hematopoietic acute radiation syndrome. Radiat Res. 198(3):221–242.
  • Patterson AM, Wu T, Chua HL, Sampson CH, Fisher A, Singh P, Guise TA, Feng H, Muldoon J, Wright L, et al. 2021. Optimizing and profiling prostaglandin E2 as a medical countermeasure for the hematopoietic acute radiation syndrome. Radiat Res. 195(2):115–127.
  • Peebles DD, Soref CM, Copp RR, Thunberg AL, Fahl WE. 2012. ROS-scavenger and radioprotective efficacy of the new PrC-210 aminothiol. Radiat Res. 178(1):57–68.
  • Plett PA, Chua HL, Sampson CH, Katz BP, Fam CM, Anderson LJ, Cox G, Orschell CM. 2014. PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 106(1):7–20.
  • Plett PA, Sampson CH, Chua HL, Jackson W, Vemula S, Sellamuthu R, Fisher A, Feng H, Wu T, MacVittie TJ, et al. 2015. The H-ARS dose response relationship (DRR): validation and variables. Health Phys. 109(5):391–398.
  • Plett PA, Sampson CH, Chua HL, Joshi M, Booth C, Gough A, Johnson CS, Katz BP, Farese AM, Parker J, et al. 2012. Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 103(4):343–355.
  • Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G. 2009. TGF-beta and fibrosis in different organs – molecular pathway imprints. Biochim Biophys Acta. 1792(8):746–756.
  • Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsui T, Nonaka H, et al. 1994. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 137(Suppl. 2):S68–S97.
  • Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K. 2004. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 162(4):377–389.
  • Qian L, Cen J. 2020. Hematopoietic stem cells and mesenchymal stromal cells in acute radiation syndrome. Oxid Med Cell Longevity. 2020:1–10.
  • Rabbani ZN, Batinic-Haberle I, Anscher MS, Huang J, Day BJ, Alexander E, Dewhirst MW, Vujaskovic Z. 2007. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys. 67(2):573–580.
  • Rabender C, Mezzaroma E, Mauro AG, Mullangi R, Abbate A, Anscher M, Hart B, Mikkelsen R. 2016. IPW-5371 proves effective as a radiation countermeasure by mitigating radiation-induced late effects. Radiat Res. 186(5):478–488.
  • Rakic P. 1974. Neurons in rhesus monkey visual cortex: systematic relation between time of origin and eventual disposition. Science. 183(4123):425–427.
  • Rauchwerger JM. 1972. Radiation protection by tibia-shielding in adult, weanling and suckling mice. I. Comparative protection studies. Int J Radiat Biol Relat Stud Phys Chem Med. 22(3):269–278.
  • Ricciotti E, FitzGerald GA. 2011. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 31(5):986–1000.
  • Robbins ME, Zhao W. 2004. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol. 80(4):251–259.
  • Roberts A, Pardo-Manuel de Villena F, Wang W, McMillan L, Threadgill DW. 2007. The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome. 18(6–7):473–481.
  • Rocheteau P, Vinet M, Chretien F. 2015. Dormancy and quiescence of skeletal muscle stem cells. Results Probl Cell Differ. 56:215–235.
  • Satyamitra MM, Cassatt DR, Taliaferro LP. 2021. Meeting commentary: a poly-pharmacy approach to mitigate acute radiation syndrome (ARS). Radiat Res. 196(4):423–428.
  • Schipper J, Tan KE, van Peperzeel HA. 1985. Treatment of retinoblastoma by precision megavoltage radiation therapy. Radiother Oncol. 3(2):117–132.
  • Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. 2007. Renin–angiotensin system and cardiovascular risk. Lancet. 369(9568):1208–1219.
  • Shakhov AN, Singh VK, Bone F, Cheney A, Kononov Y, Krasnov P, Bratanova-Toshkova TK, Shakhova VV, Young J, Weil MM, et al. 2012. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLOS One. 7(3):e33044.
  • Sharma GP, Fish BL, Frei AC, Narayanan J, Gasperetti T, Scholler D, Pierce L, Szalewski N, Blue N, Medhora M, et al. 2022. Pharmacologic ACE-inhibition mitigates radiation-induced pneumonitis by suppressing ACE-expressing lung myeloid cells. Int J Radiat Oncol Biol Phys. 113(1):177–191.
  • Sharma NK, Holmes-Hampton GP, Kumar VP, Biswas S, Wuddie K, Stone S, Aschenake Z, Wilkins WL, Fam CM, Cox GN, et al. 2020. Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059. Sci Rep. 10(1):6825.
  • Shinjo K, Takeshita A, Ohnishi K, Ohno R. 1997. Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma. 25(1–2):37–46.
  • Simone NL, Ménard C, Soule BP, Albert PS, Guion P, Smith S, Godette D, Crouse NS, Sciuto LC, Cooley-Zgela T, et al. 2008. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in quality of life measured by EPIC score. Int J Radiat Oncol Biol Phys. 70(1):90–95.
  • Singh VK, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Seed TM. 2016. The potentiation of the radioprotective efficacy of two medical countermeasures, gamma-tocotrienol and amifostine, by a combination prophylactic modality. Radiat Prot Dosimetry. 172(1–3):302–310.
  • Singh VK, Romaine PL, Seed TM. 2015. Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the strategic national stockpile. Health Phys. 108(6):607–630.
  • Singh VK, Seed TM. 2020. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure. Expert Opin Investig Drugs. 29(5):429–441.
  • Singh VK, Seed TM. 2020. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems. Expert Opin Pharmacother. 21(3):317–337.
  • Singh VK, Seed TM. 2021. Repurposing pharmaceuticals previously approved by regulatory agencies to medically counter injuries arising either early or late following radiation exposure. Front Pharmacol. 12:624844.
  • Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. 2009. Prostanoids in health and disease. J Lipid Res. 50(Suppl.):S423–S428.
  • Spalding JF, Johnson OS, Archuleta RF. 1965. Acute radio-sensitivity as a function of age in mice. Nature. 208(5013):905–906.
  • Srinivasan V, Pendergrass JA Jr, Kumar KS, Landauer MR, Seed TM. 2002. Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets. Int J Radiat Biol. 78(6):535–543.
  • Svenson KL, Gatti DM, Valdar W, Welsh CE, Cheng R, Chesler EJ, Palmer AA, McMillan L, Churchill GA. 2012. High-resolution genetic mapping using the mouse diversity outbred population. Genetics. 190(2):437–447.
  • Tichy A, Vavrova J, Pejchal J, Rezacova M. 2010. Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response. Acta Med. 53(1):13–17.
  • Unthank JL, Miller SJ, Quickery AK, Ferguson EL, Wang M, Sampson CH, Chua HL, DiStasi MR, Feng H, Fisher A, et al. 2015. Delayed effects of acute radiation exposure in a murine model of the H-ARS: multiple-organ injury consequent to <10 Gy total body irradiation. Health Phys. 109(5):511–521.
  • Unthank JL, Ortiz M, Trivedi H, Pelus LM, Sampson CH, Sellamuthu R, Fisher A, Chua HL, Plett A, Orschell CM, et al. 2019. Cardiac and renal delayed effects of acute radiation exposure: organ differences in vasculopathy, inflammation, senescence and oxidative balance. Radiat Res. 191(5):383–397.
  • U.S. FDA. 2015. FDA product development under the animal rule: guidance for industry. Silver Spring (MD): FDA.
  • Valente M, Denis J, Grenier N, Arvers P, Foucher B, Desangles F, Martigne P, Chaussard H, Drouet M, Abend M, et al. 2015. Revisiting biomarkers of total-body and partial-body exposure in a baboon model of irradiation. PLOS One. 10(7):e0132194.
  • Walden TL Jr, Patchen M, Snyder SL. 1987. 16,16-Dimethyl prostaglandin E2 increases survival in mice following irradiation. Radiat Res. 109(3):440–448.
  • Wang J, Zheng H, Hauer-Jensen M. 2001. Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor beta (TGF-beta) overexpression, and collagen accumulation in irradiated rat intestine. J Pharmacol Exp Ther. 297(1):35–42.
  • Wang J, Zheng H, Sung CC, Hauer-Jensen M. 1999. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys. 45(5):1289–1296.
  • Wang Y, Boerma M, Zhou D. 2016. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Radiat Res. 186(2):153–161.
  • Wang Y, Liu L, Pazhanisamy SK, Li H, Meng A, Zhou D. 2010. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med. 48(2):348–356.
  • Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D. 2006. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood. 107(1):358–366.
  • Williams JP, Brown SL, Georges GE, Hauer-Jensen M, Hill RP, Huser AK, Kirsch DG, Macvittie TJ, Mason KA, Medhora MM, et al. 2010. Animal models for medical countermeasures to radiation exposure. Radiat Res. 173(4):557–578.
  • Williams JP, Johnston CJ, Finkelstein JN. 2010. Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets. 11(11):1386–1394.
  • Winters TA, Cassatt DR, Harrison-Peters JR, Hollingsworth BA, Rios CI, Satyamitra MM, Taliaferro LP, DiCarlo AL. 2023. Considerations of medical preparedness to assess and treat various populations during a radiation public health emergency. Radiat Res.
  • Woodcock EA, Matkovich SJ. 2005. Cardiomyocytes structure, function and associated pathologies. Int J Biochem Cell Biol. 37(9):1746–1751.
  • Wu T, Plett PA, Chua HL, Jacobsen M, Sandusky GE, MacVittie TJ, Orschell CM. 2020. Immune reconstitution and thymic involution in the acute and delayed hematopoietic radiation syndromes. Health Phys. 119(5):647–658.
  • Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. 2004. Noncancer disease incidence in atomic bomb survivors, 1958–1998. Radiat Res. 161(6):622–632.
  • Yamada MK. 2016. A link between vascular damage and cognitive deficits after whole-brain radiation therapy for cancer: a clue to other types of dementia? Drug Discov Ther. 10(2):79–81.
  • Yang L, Wang R, Gao Y, Xu X, Fu K, Wang S, Li Y, Peng R. 2014. The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways. Dig Dis Sci. 59(7):1406–1414.
  • Yarom R, Harper IS, Wynchank S, van Schalkwyk D, Madhoo J, Williams K, Salie R, Genade S, Lochner A. 1993. Effect of captopril on changes in rats’ hearts induced by long-term irradiation. Radiat Res. 133(2):187–197.
  • Yu H, Shen H, Yuan Y, XuFeng R, Hu X, Garrison SP, Zhang L, Yu J, Zambetti GP, Cheng T. 2010. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood. 115(17):3472–3480.
  • Yuhas JM, Yurconic M, Kligerman MM, West G, Peterson DF. 1977. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy. Radiat Res. 70(2):433–443.
  • Zhao W, Robbins ME. 2009. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem. 16(2):130–143.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.